Advances in positron emission tomography technology have increased the need for surgical staging in non–small cell lung cancer
- 1 March 2007
- journal article
- Published by Elsevier BV in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 133 (3), 746-752
- https://doi.org/10.1016/j.jtcvs.2006.10.043
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Cancer Statistics, 2006CA: A Cancer Journal for Clinicians, 2006
- Improving the Inaccuracies of Clinical Staging of Patients with NSCLC: A Prospective TrialThe Annals of Thoracic Surgery, 2005
- Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung CancerNew England Journal of Medicine, 2005
- Adjuvant Chemotherapy for Non–Small-Cell Lung Cancer — The Smoke ClearsNew England Journal of Medicine, 2005
- Meta-Analysis of Positron Emission Tomographic and Computed Tomographic Imaging in Detecting Mediastinal Lymph Node Metastases in Nonsmall Cell Lung CancerThe Annals of Thoracic Surgery, 2005
- Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non–small cell lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 2003
- Noninvasive Staging of Non-small Cell Lung Cancer*Chest, 2003
- Whole-body FDG-PET imaging in the management of patients with cancerSeminars in Nuclear Medicine, 2002
- Treatment of Stage I and II Non-Small-Cell Lung CancerCancer Control, 2001
- Role of multimodality treatment for lung cancerSeminars in Surgical Oncology, 2000